by GMFH Editing Team
A clear consensus on the mechanisms of action of food intolerances doesn’t exist due to their heterogeneous nature. A new narrative review sheds light on the scientific background of the mechanisms, diagnosis and management of food intolerances.
Circadian rhythms are also apparent within our gastrointestinal tract. Two new mice studies show that circadian rhythm and clock genes may also affect intestinal immune cells by boosting the secretion of cytokines that help maintain proper balance of the intestinal barrier.
by GMFH Editing Team
A wide range of factors are involved in driving the onset of IBS, with certain food items considered important triggers. Learn more about the latest scientific evidence regarding dietary management of IBS in this narrative review.
by GMFH Editing Team
Interviewed at the 8th Gut Microbiota for Health World Summit 2019 in Miami (USA), Natasha Haskey analyzes what happens in the gut microbiota when we change our diet.
by GMFH Editing Team
Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.
Aging-related changes also occur within our digestive tract. Diet and host genetics are critical determinants of gut microbial composition and function, whose origins go back to the moment of birth.
by Manon Oliero
A new publication from Alan T. Tang of the University of Pennsylvania focuses on explaining the relationship between gut microbiota and cerebral cavernous malformation (CCM), which is a neurological disease that leads to hemorrhagic stroke and seizure.
by Andreu Prados
Probiotics constitute a promising strategy for altering intestinal motility. New mice research reveals that the probiotic Lactobacillus rhamnosus GG releases formylated peptides that modulate enteric neurons and accelerate gastrointestinal motility.
by GMFH Editing Team
Imbalances in the gut microbiota composition have been described as a hallmark of certain liver diseases. Yi Duan from the University of California San Diego and colleagues have found in mice that specific phages targeting the gut-dwelling bacterium E. faecalis might be used to treat patients with alcoholic hepatitis.
2019 is ending with major progress in gut microbiota research. Do you want to know which are the 10 most popular articles of 2019 in the News Watch section of Gut Microbiota for Health?
